Annual report

Period2022-04-01 → 2023-03-31
Filed2023-06-21
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 154
MetricValuePeriodScopeSource row
Revenue¥1.02T2022-04-01 → 2023-03-31Cons.Net sales
Revenue¥926.1bn2021-04-01 → 2022-03-31Cons.Net sales
Revenue¥836.5bn2020-04-01 → 2021-03-31dCons.Net sales (5-year summary)
Revenue¥853.7bn2019-04-01 → 2020-03-31dCons.Net sales (5-year summary)
Revenue¥888.6bn2018-04-01 → 2019-03-31dCons.Net sales (5-year summary)
Operating income¥12.9bn2022-04-01 → 2023-03-31Cons.Operating income
Operating income¥44.2bn2021-04-01 → 2022-03-31Cons.Operating income
Ordinary income¥9.1bn2022-04-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥49.7bn2021-04-01 → 2022-03-31Cons.Ordinary income
Ordinary income¥53.7bn2020-04-01 → 2021-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥54.3bn2019-04-01 → 2020-03-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥60.3bn2018-04-01 → 2019-03-31dCons.Ordinary income loss (5-year summary)
Profit before tax−¥1.5bn2022-04-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥44.1bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)−¥17.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥23.2bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥6.7bn2020-04-01 → 2021-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥25.3bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥45.1bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income−¥15.8bn2022-04-01 → 2023-03-31Cons.Profit loss
Net income¥26.0bn2021-04-01 → 2022-03-31Cons.Profit loss
Total assets¥1.24Tat 2023-03-31Cons.Assets
Total assets¥1.21Tat 2022-03-31Cons.Assets
Total assets¥1.04Tat 2021-03-31dCons.Total assets (5-year summary)
Total assets¥1.00Tat 2020-03-31dCons.Total assets (5-year summary)
Total assets¥1.02Tat 2019-03-31dCons.Total assets (5-year summary)
Total liabilities¥791.3bnat 2023-03-31Cons.Liabilities
Total liabilities¥742.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥451.1bnat 2023-03-31Cons.Net assets
Net assets / equity¥464.8bnat 2022-03-31Cons.Net assets
Net assets / equity¥430.4bnat 2021-03-31dCons.Net assets
Net assets / equity¥411.4bnat 2020-03-31dCons.Net assets (5-year summary)
Net assets / equity¥427.2bnat 2019-03-31dCons.Net assets (5-year summary)
Cash and deposits¥142.8bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥134.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥140.3bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥130.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥166.5bnat 2021-03-31dCons.Cash and cash equivalents
Cash & equivalents¥156.3bnat 2020-03-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥140.4bnat 2019-03-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥55.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥89.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥107.7bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥94.2bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥80.9bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥52.4bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥198.4bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥79.6bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥67.9bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥41.3bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥7.2bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥71.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥20.9bn2020-04-01 → 2021-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥8.1bn2019-04-01 → 2020-03-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥15.4bn2018-04-01 → 2019-03-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥-92.042022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥120.582021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-34.72020-04-01 → 2021-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥131.632019-04-01 → 2020-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥232.392018-04-01 → 2019-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥115.722021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥124.432019-04-01 → 2020-03-31dCons.Diluted earnings per share (5-year summary)
EPS (diluted)¥214.352018-04-01 → 2019-03-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥2,209.82at 2023-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥2,288.05at 2022-03-31Cons.Net assets per share (5-year summary)
Net assets per share¥2,115.61at 2021-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥2,053.57at 2020-03-31dCons.Net assets per share (5-year summary)
Net assets per share¥2,141.3at 2019-03-31dCons.Net assets per share (5-year summary)
Equity ratio34.2%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio36.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.0%at 2021-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2020-03-31dCons.Equity to asset ratio (5-year summary)
Equity ratio40.2%at 2019-03-31dCons.Equity to asset ratio (5-year summary)
ROE-4.1%2022-04-01 → 2023-03-31Cons.Rate of return on equity (5-year summary)
ROE5.5%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
ROE-1.7%2020-04-01 → 2021-03-31dCons.Rate of return on equity (5-year summary)
ROE6.3%2019-04-01 → 2020-03-31dCons.Rate of return on equity (5-year summary)
ROE11.2%2018-04-01 → 2019-03-31dCons.Rate of return on equity (5-year summary)
Employees22,484at 2023-03-31Cons.Number of employees
Employees21,815at 2022-03-31Cons.Number of employees
Employees21,090at 2021-03-31dCons.Number of employees
Employees20,075at 2020-03-31dCons.Number of employees
Employees20,671at 2019-03-31dCons.Number of employees
Revenue¥140.8bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥139.4bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥110.0bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥124.4bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥133.5bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Operating income¥7.4bn2022-04-01 → 2023-03-31StandaloneOperating income
Operating income¥10.5bn2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥115.1bn2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥27.7bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥17.0bn2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥32.3bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥44.2bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥13.4bn2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Profit before tax¥37.9bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income−¥16.1bn2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥36.1bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥14.7bn2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥28.5bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥32.0bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Total assets¥626.7bnat 2023-03-31StandaloneAssets
Total assets¥638.8bnat 2022-03-31StandaloneAssets
Total assets¥559.5bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥559.3bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥563.5bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥390.1bnat 2023-03-31StandaloneLiabilities
Total liabilities¥374.0bnat 2022-03-31StandaloneLiabilities
Net assets / equity¥236.7bnat 2023-03-31StandaloneNet assets
Net assets / equity¥264.9bnat 2022-03-31StandaloneNet assets
Net assets / equity¥239.3bnat 2021-03-31dStandaloneNet assets
Net assets / equity¥256.6bnat 2020-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥249.2bnat 2019-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥50.6bnat 2023-03-31StandaloneCash and deposits
Cash and deposits¥57.5bnat 2022-03-31StandaloneCash and deposits
EPS (basic)¥-83.62022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥188.162021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-76.422020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥148.52019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥165.012018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥180.592021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥140.382019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥152.182018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥402022-04-01 → 2023-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥552021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥502020-04-01 → 2021-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥602019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥702018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥1,228.24at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,375.63at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥1,243.18at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,333.56at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥1,295.63at 2019-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio37.7%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio41.4%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio42.7%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.8%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio44.1%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE-6.4%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE14.4%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE-5.9%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE11.3%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE13.0%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued197,953,707at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued197,953,707at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees2,874at 2023-03-31StandaloneNumber of employees
Employees2,890at 2022-03-31StandaloneNumber of employees
Employees2,880at 2021-03-31dStandaloneNumber of employees
Employees2,819at 2020-03-31dStandaloneNumber of employees
Employees2,639at 2019-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 76
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2022-04-01 → 2023-03-31¥2.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2022-04-01 → 2023-03-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2023-03-311591 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2023-03-31¥34.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2023-03-31¥30.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2023-03-31¥4.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2023-03-31¥90.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2023-03-31−¥2.4bn
Healthcarereportable segmentcapex2022-04-01 → 2023-03-31¥8.7bn
Healthcarereportable segmentdepreciation2022-04-01 → 2023-03-31¥26.0bn
Healthcarereportable segmentemployeesat 2023-03-313155 pure
Healthcarereportable segmentrevenue2022-04-01 → 2023-03-31¥152.4bn
Healthcarereportable segmentrevenue external2022-04-01 → 2023-03-31¥152.4bn
Healthcarereportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥16m
Healthcarereportable segmentsegment assetsat 2023-03-31¥229.0bn
Healthcarereportable segmentsegment profit2022-04-01 → 2023-03-31¥23.5bn
Materialreportable segmentcapex2022-04-01 → 2023-03-31¥43.2bn
Materialreportable segmentdepreciation2022-04-01 → 2023-03-31¥34.0bn
Materialreportable segmentemployeesat 2023-03-3111048 pure
Materialreportable segmentrevenue2022-04-01 → 2023-03-31¥466.8bn
Materialreportable segmentrevenue external2022-04-01 → 2023-03-31¥456.0bn
Materialreportable segmentrevenue intersegment2022-04-01 → 2023-03-31¥10.8bn
Materialreportable segmentsegment assetsat 2023-03-31¥575.6bn
Materialreportable segmentsegment profit2022-04-01 → 2023-03-31−¥20.4bn
—segment totalcapex2022-04-01 → 2023-03-31¥58.9bn
—segment totaldepreciation2022-04-01 → 2023-03-31¥67.7bn
—segment totalrevenue2022-04-01 → 2023-03-31¥1.01T
—segment totalrevenue external2022-04-01 → 2023-03-31¥988.2bn
—segment totalrevenue intersegment2022-04-01 → 2023-03-31¥19.8bn
—segment totalsegment assetsat 2023-03-31¥1.08T
—segment totalsegment profit2022-04-01 → 2023-03-31¥21.1bn
Total Of Reportable Segments And Otherssegment totalcapex2022-04-01 → 2023-03-31¥61.6bn
Total Of Reportable Segments And Otherssegment totaldepreciation2022-04-01 → 2023-03-31¥70.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2023-03-31¥1.04T
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2023-03-31¥1.02T
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2023-03-31¥24.0bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-03-31¥1.17T
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2023-03-31¥18.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentscapex2021-04-01 → 2022-03-31¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2021-04-01 → 2022-03-31¥2.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2022-03-31¥33.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2022-03-31¥29.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2022-03-31¥3.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥88.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2022-03-31−¥2.3bn
Healthcarereportable segmentcapex2021-04-01 → 2022-03-31¥145.7bn
Healthcarereportable segmentdepreciation2021-04-01 → 2022-03-31¥26.3bn
Healthcarereportable segmentrevenue2021-04-01 → 2022-03-31¥175.1bn
Healthcarereportable segmentrevenue external2021-04-01 → 2022-03-31¥175.1bn
Healthcarereportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥15m
Healthcarereportable segmentsegment assetsat 2022-03-31¥260.1bn
Healthcarereportable segmentsegment profit2021-04-01 → 2022-03-31¥43.3bn
Materialreportable segmentcapex2021-04-01 → 2022-03-31¥44.7bn
Materialreportable segmentdepreciation2021-04-01 → 2022-03-31¥27.1bn
Materialreportable segmentrevenue2021-04-01 → 2022-03-31¥397.5bn
Materialreportable segmentrevenue external2021-04-01 → 2022-03-31¥385.1bn
Materialreportable segmentrevenue intersegment2021-04-01 → 2022-03-31¥12.4bn
Materialreportable segmentsegment assetsat 2022-03-31¥522.2bn
Materialreportable segmentsegment profit2021-04-01 → 2022-03-31−¥5.7bn
—segment totalcapex2021-04-01 → 2022-03-31¥197.5bn
—segment totaldepreciation2021-04-01 → 2022-03-31¥61.0bn
—segment totalrevenue2021-04-01 → 2022-03-31¥918.0bn
—segment totalrevenue external2021-04-01 → 2022-03-31¥896.4bn
—segment totalrevenue intersegment2021-04-01 → 2022-03-31¥21.6bn
—segment totalsegment assetsat 2022-03-31¥1.04T
—segment totalsegment profit2021-04-01 → 2022-03-31¥52.9bn
Total Of Reportable Segments And Otherssegment totalcapex2021-04-01 → 2022-03-31¥199.7bn
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥63.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥951.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥926.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2022-03-31¥25.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥1.13T
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥50.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2023-03-31366 pure
Healthcarereportable segmentemployeesat 2023-03-31195 pure
Materialreportable segmentemployeesat 2023-03-311947 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,979
ItemContextValueUnit
Decrease increase in short term loans receivable inv cfPrior1YearDuration-2263000000JPY
Decrease increase in short term loans receivable inv cfCurrentYearDuration-1643000000JPY
Other net inv cfPrior1YearDuration-813000000JPY
Other net inv cfCurrentYearDuration-1309000000JPY
Net cash provided by used in investment activitiesPrior1YearDuration-198375000000JPY
Net cash provided by used in investment activitiesCurrentYearDuration-52427000000JPY
Net increase decrease in short term loans payable fin cfPrior1YearDuration9423000000JPY
Net increase decrease in short term loans payable fin cfCurrentYearDuration16223000000JPY
Proceeds from issuance of bonds fin cfPrior1YearDuration90000000000JPY
Proceeds from issuance of bonds fin cfCurrentYearDuration-JPY
Redemption of bonds fin cfPrior1YearDuration-20000000000JPY
Redemption of bonds fin cfCurrentYearDuration-JPY
Proceeds from long term loans payable fin cfPrior1YearDuration23529000000JPY
Proceeds from long term loans payable fin cfCurrentYearDuration41500000000JPY
Repayment of long term loans payable fin cfPrior1YearDuration-16439000000JPY
Repayment of long term loans payable fin cfCurrentYearDuration-37150000000JPY
Purchase of treasury stock fin cfPrior1YearDuration-18000000JPY
Purchase of treasury stock fin cfCurrentYearDuration-5000000JPY
Cash dividends paid fin cfPrior1YearDuration-10082000000JPY
Cash dividends paid fin cfCurrentYearDuration-10571000000JPY
Dividends paid to non controlling interests fin cfPrior1YearDuration-953000000JPY
Dividends paid to non controlling interests fin cfCurrentYearDuration-1315000000JPY
Other net fin cfPrior1YearDuration-4346000000JPY
Other net fin cfCurrentYearDuration-1501000000JPY
Net cash provided by used in financing activitiesPrior1YearDuration71113000000JPY
Net cash provided by used in financing activitiesCurrentYearDuration7180000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration1841000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration-658000000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration-35764000000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration9182000000JPY
Cash and cash equivalentsPrior2YearInstant166455000000JPY
Cash and cash equivalentsPrior1YearInstant130696000000JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation ccePrior1YearDuration-JPY
Increase decrease in cash and cash equivalents resulting from change of scope of consolidation cceCurrentYearDuration428000000JPY
Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries ccePrior1YearDuration5000000JPY
Increase in cash and cash equivalents resulting from merger with unconsolidated subsidiaries cceCurrentYearDuration-JPY
Cash and cash equivalentsPrior1YearInstant130696000000JPY
Cash and cash equivalentsCurrentYearInstant140307000000JPY
Number of consolidated subsidiariesCurrentYearInstant98
Number of unconsolidated subsidiaries accounted for using equity methodCurrentYearInstant44
Number of associates accounted for using equity methodCurrentYearInstant21
Accumulated depreciation ppe by groupPrior1YearInstant-718875000000JPY
Accumulated depreciation ppe by groupCurrentYearInstant-767892000000JPY
Discounted trade notes receivablePrior1YearInstant271000000JPY
Discounted trade notes receivableCurrentYearInstant355000000JPY
Contract assetsPrior1YearInstant5513000000JPY
Contract assetsCurrentYearInstant2912000000JPY
Contract liabilitiesPrior1YearInstant4448000000JPY
Contract liabilitiesCurrentYearInstant4617000000JPY
Write downs of inventoriesPrior1YearDuration-56000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2023-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2023-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2021-03-31pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass